Dental Practice Succession Planning: How To Choose Your Path

Key Takeaways

• Dental practice succession planning often centers on four primary paths: doctor-to-doctor private sale, DSO or private equity affiliation, associate buy-in, and family transfer. Each path creates a different mix of cash, equity, autonomy, and transition timeline.

• The right path can be shaped by practice revenue, EBITDA margin, specialty, and the owner’s personal goals. Practices under $1.5M in collections often favor private sales, while practices above $3M frequently lean toward DSO affiliation.

• Deal details such as cash at close, rollover equity, earnouts, and work-back obligations can be some of the main factors that determine the owner’s actual proceeds and post-sale experience.

• Owners who begin planning 5–10 years ahead and work with dental-specific advisors often see higher valuations and smoother transitions than owners who wait until the final 3 years before exit.

• McLerran & Associates provides side-by-side valuations across both private-buyer and DSO channels, which can support higher transaction rates and stronger outcomes for selling dentists.

Schedule A Free, Confidential Discovery Call With McLerran & Associates.

Succession Options At A Glance: Cash, Control, And Timeline

The four main succession paths differ most in how much cash you receive at closing, how long you stay involved, and how much control you keep. The table below compares all four across those dimensions so you can see where each path trades certainty for upside. Valuation figures are general ranges drawn from industry sources and are not guarantees of any specific outcome. Consult your own tax and legal advisors before making any decision.

Dimension	Doctor-To-Doctor Private Sale	Dso / Private Equity Affiliation	Associate Buy-In	Family Transfer
How It Works	Practice assets are sold outright to a buying dentist, typically financed through an SBA or conventional practice loan.	The practice affiliates with a corporate platform. The owner receives cash, rollover equity, and often an earnout in exchange for joining the DSO’s infrastructure.	An associate already in the practice purchases equity in stages. Commonly 25–50% sells now, with a defined path to full ownership.	Ownership transfers to a family member, usually through seller financing, gifting, or a phased buy-in over several years.
Typical Timeline	Roughly 4–8 months from listing to close. The seller usually works back about 4–8 weeks after closing.	A 45–60-day competitive bid process is common. A 3–5 year post-close employment agreement is typical.	A full transition often takes 2–7 years, and the associate commonly works in the practice 3–5 years before buy-in begins.	Transitions typically run 2–7 years and follow a gradual handoff with mentorship and seller financing.
Cash At Close	Most or all of the price is paid in cash at closing. Phased external sales often produce roughly 80% cash at close.	DSO deals typically pay 60–75% in cash at close, with 15–30% as rollover equity and 5–15% as an earnout. DSO sales average roughly 70% cash at close.	Roughly 53% of the price is paid in cash at close. The remainder is usually a seller-held note paid from practice earnings.	Cash certainty is lowest. Deals are heavily seller-financed, and proceeds arrive over years instead of at a single closing.
Control Retained After The Deal	The seller does not retain control and exits after a short work-back period.	Clinical autonomy is generally preserved. Non-clinical functions such as billing, HR, and supply chain move to the DSO. AGD member surveys document post-close dissatisfaction with scheduling and insurance participation changes.	In most associate buy-in structures, the senior partner keeps majority control until the buyout is complete. That includes the authority to override the junior partner on major operational and financial decisions. The transition is gradual.	The seller can set the pace of the handoff. Legacy and culture usually remain most intact in this structure.
Best-Fit Practice Profile	Practices commonly in the $1–1.5M revenue range where the owner wants a clean exit and has a strong patient base that can transfer to a new dentist.	Practices generally at $1.5M revenue and above where the owner wants infrastructure support, growth capital, or a partial exit while continuing to practice. DSO acquisition interest is highly selective for practices with $1.5M+ in collections and EBITDA margins above 25%.	Practices with an associate already in place who has built patient relationships. Owners often prioritize legacy continuity and cash certainty, even if the headline price is lower than a DSO offer.	Situations where a family member is a licensed dentist with the clinical and business skills to run the practice, and the owner places legacy ahead of maximum financial outcome.

How To Choose A Path By Practice Size And Specialty

The right succession path usually reflects practice size, specialty, and the owner’s personal “why,” such as reducing administrative burden, taking chips off the table, protecting staff and patients, or planning a full exit.

By Revenue: Practices in the $1–1.5M revenue range often fit a doctor-to-doctor sale, where a well-qualified individual buyer can secure conventional financing. Practices at $3M and above frequently align with the DSO or private equity path, where institutional buyers can underwrite greater scale and complexity. Practices in the $1.5–3M “Venn diagram middle” can go either way, and owners in this range benefit from seeing their value in both markets before deciding.

By Specialty: Oral and maxillofacial surgery can command some of the highest multiples and remains among the fastest-consolidating segments. Orthodontics and pediatric dentistry draw strong DSO interest. General dentistry still earns aggressive, near-all-time-high valuations. Lighter-demand specialties such as prosthodontics tend to sit at the lower end of the range. Multiples within any specialty vary materially. The main drivers are EBITDA margin, owner dependency, associate depth, payer mix, and geography.

This context is where McLerran & Associates, the nation’s largest dental-specific sell-side M&A advisory and brokerage firm, can provide a structural advantage. McLerran runs both the private-buyer and DSO paths in roughly equal measure, with approximately a 50/50 split across its roughly 2,000 completed practice sales and approximately $2 billion in closed transaction volume. That breadth supports a true side-by-side valuation that quantifies a practice’s worth in both markets.

McLerran’s CPA-led, diligence-grade EBITDA analysis is completed up front. EBITDA stands for earnings before interest, taxes, depreciation, and amortization, and it measures a practice’s operating profitability after normalizing for owner compensation and one-time expenses. Because the analysis is done at this level, the number tends to hold when buyers scrutinize it, which reduces the risk of renegotiation. The firm’s structured, auction-style bid process typically runs 45–60 days and generates around 10 offers from a vetted, pre-qualified buyer pool, with poorly run DSOs blacklisted. The result is a transaction rate of roughly 85–90%, compared with an industry norm closer to 35–40%, and on average roughly 30% higher valuations than owners often achieve selling on their own.

Regional offices led by dental-market specialists, including Justin Klingshim in Cleveland, Matt Sutton in Atlanta, Andrew Kobylski in Northern Virginia, Steven Au in Los Angeles, and Brian Carroll in Phoenix covering the Mountain West, help McLerran read local buyer appetite and market dynamics instead of relying only on national averages.

How To Choose The Best Dental Practice Broker explains what to look for in an advisor in more detail.

Deal-Structure Mechanics In Plain Language

The headline number in a dental practice offer rarely matches what the owner ultimately keeps. The structure beneath that number can be some of the main factors that determine the real outcome.

Cash At Close is the portion paid immediately at closing and is usually the most certain part of any deal. In a doctor-to-doctor sale, this amount is typically most or all of the purchase price. In a DSO deal, cash at close commonly runs 60–75% of the total consideration, with the remainder deferred.

Rollover Equity is the portion of the purchase price the seller receives as an ownership stake in the DSO’s platform instead of cash. This equity is illiquid until the DSO recapitalizes or is sold, typically within 3–7 years. Equity can be held at two levels:

• Joint-Venture (JV) Level Equity represents ownership in the local practice entity. It typically pays distributions from the practice’s profits, which creates a higher floor but a lower ceiling on upside.

• Holding-Company Equity represents ownership in the DSO’s parent platform. It usually does not pay distributions, but the upside can be higher if the platform sells at a premium multiple. The value can also be lower if the platform underperforms.

As much as 40% of a DSO deal can be paid in equity instead of cash, so owners often benefit from evaluating the DSO as carefully as they would any investment. That evaluation can include profitability, revenue growth, management depth, and the track record of the private equity backer.

Earnouts defer part of the purchase price and tie payment to post-close performance. Targets are typically based on EBITDA or collections over 12–36 months. Earnout provisions tied to post-close revenue targets are routine in DSO acquisitions. Non-punitive earnouts often include pro-rata provisions, so a near-miss on a target still pays most of the earnout. They may also start later to account for integration disruption. Punitive earnouts tie payment to individual production and require the seller to remain employed. The IRS may recharacterize such earnouts as deferred compensation taxed as ordinary income instead of capital gains. A tax advisor should review any earnout structure before you sign.

Work-Back Obligations: A minimum 5-year working agreement is typical on a DSO deal. On a private walk-away sale, the seller usually works back only about 4–8 weeks before exiting.

Capital-Gains Treatment: In a typical dental practice asset sale, the tax treatment depends on the asset class:

• Goodwill is taxed at long-term capital gains rates for the seller.

• Equipment sales trigger depreciation recapture taxed as ordinary income.

• Non-compete payments are taxed as ordinary income.

Many DSO deals can be structured so that a large share of the proceeds receives long-term capital gains treatment. The allocation of the purchase price across asset classes, which is negotiated in the purchase agreement, often determines the final tax outcome. A CPA and M&A attorney should review this allocation before any letter of intent is signed.

McLerran prepares multi-year, multi-structure financial forecasts across 3-, 5-, 7-, and 10-year horizons. These models help owners compare real after-tax proceeds across deal structures instead of focusing only on headline numbers.

Rules Of Thumb Dentists Cite And How They Relate To Succession

Before relying on any simple rule, it helps to separate heuristics that apply to succession from those that come from other parts of dentistry. Several rules of thumb circulate in dental practice conversations, and some are more relevant to transition planning than others.

What Are The 5 D’s Of Succession Planning?

The 5 D’s of succession planning, as identified by the Exit Planning Institute, are five unplanned events that can force an involuntary practice transition: Death, Disability, Divorce (including partnership dissolution), and Distress (financial). Approximately 30% of dental practice transitions occur under urgency conditions such as health events, death, partnership dissolution, or financial distress. These events compress negotiating room and planning timelines. The 5 D’s highlight that succession planning also serves as a contingency plan. A practical emergency plan usually specifies who can manage the practice, how ownership can transfer, how the practice will be valued, and how staff and patients will be informed.

What Is The 50-40-30 Rule In Dentistry?

The 50-40-30 rule is a patient acquisition and marketing framework, not a succession or valuation formula. It describes a diversification target for new patient sourcing, with roughly half from referrals, a significant portion from digital marketing, and the remainder from other channels. The goal is to avoid over-reliance on any single acquisition source. Some practice management sources also use the phrase as a shorthand for overhead benchmarks, such as roughly 50% of collections to overhead and 40% to net income before tax, but interpretations vary and a dental CPA should confirm any ratio against actual practice data. Neither version of the 50-40-30 rule functions as a succession planning rule, so it should not be used as a valuation input.

What Is The 2-2-2 Rule In Dentistry?

The 2-2-2 rule is a patient education and preventive care framework: brush twice a day, floss twice a day, and visit the dentist twice a year. Practices that embed this message in recall communications often see steadier hygiene appointment volume and stronger long-term patient loyalty. This rule does not apply to succession planning, deal structure, or valuation.

Downsides Of Each Succession Option And Owner Responsibilities

Every succession path carries tradeoffs and risks, and understanding them clearly can support better decisions.

Doctor-To-Doctor Private Sale: The buyer pool is smaller, and finding a well-qualified individual buyer through a local network can be harder than it appears. Do-it-yourself close rates can run as low as 15–20%, compared with roughly 80% for a well-run brokered process. Pricing the practice accurately without a diligence-grade valuation is challenging, and a weak number can quietly anchor the final outcome.

Dso / Private Equity Affiliation: The owner negotiates with a counterparty that structures deals every week, which creates a real information gap. DSO sales expose sellers to 15–25% earnout risk, and a significant portion of the deal can be paid in equity that remains illiquid until the DSO recapitalizes. Distinguishing strong DSOs from weaker ones requires careful vetting. If the DSO is acquired, restructured, or underperforms during the seller’s work-back period, deferred value may not materialize as expected.

Associate Buy-In: Private Practice Research identifies five common failure modes in internal associate buy-in structures: mispriced minority, financing-structure mismatch, owner exit timeline conflict, production-share misalignment, and misreading the associate’s readiness for ownership. Associates typically carry $200,000–$300,000 or more in student debt, which can limit financing options and extend timelines. The headline price is usually lower than a DSO offer, even though continuity can be higher.

Family Transfer: Proceeds often arrive over many years instead of at a single closing. The family member must be both a capable clinician and a capable business operator. Blending family relationships with financial negotiations can introduce emotional complexity that affects both the deal and the relationship.

Who Is Responsible For The Plan? The owner ultimately drives the succession plan. An experienced sell-side advisor can coordinate valuation, buyer outreach, diligence, and closing, but the owner still needs to understand the options, clarify goals, and make final decisions. Practical succession plan examples can help owners picture a completed plan before engaging an advisor.

Hybrid And Emergency Succession Scenarios To Consider

Many real-world transitions blend elements of the four core paths. Several hybrid and emergency structures appear frequently and can be useful to understand.

Partial Sale / Partnership Vest-Out: An owner sells roughly 50% of the practice now to a future partner, often an associate already in the practice, who then buys the remaining share over time. This structure provides immediate liquidity while preserving continuity for staff and patients. It is one of the two primary structures McLerran uses on the private-buyer side.

Merger: Two practices combine into a single entity, and the merging doctors share ownership. This approach can expand the buyer pool for a future sale and reduce overhead per location. Integration often takes 6–18 months and requires careful alignment on culture, systems, and governance.

Asset Sale Vs. Entity Sale: More than 95% of dental practice sales are structured as asset sales instead of stock sales, largely because state dental board licensing regulations make transferring the professional entity impractical. The distinction can matter for tax allocation, so a CPA and attorney should review the structure.

Emergency Succession: A practical emergency plan usually specifies who can manage the practice, how ownership can transfer, how the practice will be valued, how the transaction will be funded, and how staff and patients will be informed. Without a documented plan, a health event or death can force a distressed sale at a fraction of the practice’s likely value.

Key Trends In Dental Practice Succession Planning For 2026

The dental M&A market in 2026 reflects several converging forces that owners approaching a transition may want to understand.

Dso Consolidation Continues: About 16.1% of U.S. dentists were affiliated with a DSO in 2024, up from 7.2% in 2015, which represents more than a doubling over that period. The global DSO market is projected to grow at 17.4% annually through 2032, and DSOs entered new U.S. states throughout 2026, including a Canada-based group entering the U.S. market for the first time.

A Wave Of Recapitalizations Is Building: More than 20 private-equity-backed dental platforms are seven or more years into their hold periods, which sets up a wave of DSO recapitalizations, secondary sales, and potential IPOs.

Financing Conditions Have Tightened: The Federal Reserve raised its target rate to 3.75%–4.00% on September 16, 2026, and new SBA underwriting rules took effect October 1, 2026, which adds pressure on associate buyers financing private acquisitions. This shift can narrow the private-buyer pool for practices in certain revenue ranges and can make the DSO path relatively more competitive for some owners.

Demand For Premier Practices Remains Steep: Platform and portfolio DSOs targeting practices with $1.5M or more in collections have competed aggressively for mid-career practitioners since 2018, offering cash multiples that exceeded traditional benchmarks by 15–30% on high-EBITDA practices. Valuations for Class A assets remain near all-time highs. FOCUS Investment Banking noted in its 2026 Dental Transaction Market Commentary that the spread between best-tier and middle-tier DSO offers for dental practices has widened significantly, which means the quality of the process and the advisor running it can influence which tier of offer an owner receives.

The Seller Pool Is Growing: About 33.8% of U.S. dentists are now 55 or older, and the average retirement age has risen to 68.7 years. More owners are approaching the transition window at the same time, which can reinforce the value of acting before the market becomes more crowded.

Find Out What Your Practice Is Really Worth. Request A Comprehensive Practice Valuation.

Frequently Asked Questions

Should I Sell To A Private Buyer Or A DSO?

The choice often depends on practice size, profitability, and your personal goals. As the revenue thresholds above suggest, practices in the $1–1.5M range often fit a private doctor-to-doctor sale, while practices at $3M and above frequently align with the DSO path. Owners in the $1.5–3M middle can genuinely go either way and usually benefit from seeing their value in both markets before deciding. Because McLerran & Associates works both paths in roughly equal measure, it can provide a side-by-side valuation so you choose with more complete information.

Why Pay For A Valuation When Some Firms Do It For Free?

A free valuation usually functions as a lead-generation tool and often produces a rough number that may not hold up under buyer scrutiny. When a buyer’s quality-of-earnings team examines the practice during due diligence, a weak valuation can be renegotiated down and the deal can be re-traded. McLerran’s CPA-led EBITDA analysis is diligence-grade work done up front, which helps the number hold when buyers look closely. In one documented case, a free valuation pegged a practice at $2.5M. McLerran valued it at $4.5M, and it sold for $5.25M after a competitive process. In that context, the valuation functions less as a cost and more as the foundation of the outcome.

What Multiple Will My Practice Sell For?

Multiples are driven by fundamentals rather than a fixed table. Larger practices with deeper associate benches, more durable revenue, and higher EBITDA margins tend to command higher multiples. Specialty also plays a role. Oral and maxillofacial surgery and orthodontics can command stronger multiples than general dentistry, although general dentistry still earns aggressive valuations near all-time highs. Payer mix, owner dependency, equipment condition, and geography can all move the number in either direction. A diligence-grade valuation can quantify how these factors apply to your specific practice.

How Do I Know Which DSOs Are Strong Fits?

Evaluating DSOs is a core part of McLerran’s work. Among the hundreds of DSOs active in the market, some are well-backed, well-run, and have a track record of satisfied sellers. Others emerged when capital flooded the space after COVID and may be undercapitalized or poorly managed. McLerran has blacklisted DSOs known for creating poor post-close environments, so they do not reach the table. Owners can also evaluate a DSO the way they would evaluate an investment by asking whether the company is profitable, whether revenue is growing at existing offices, whether the management team is experienced, and whether the private equity sponsor has completed similar deals successfully.

Are DSO Deals All Cash, Or Is There Stock Involved?

Most DSO deals combine cash at close, rollover equity, and an earnout. Rollover equity can be held at the joint-venture level, which is ownership in the local practice entity that pays distributions, or at the holding-company level, which does not pay distributions but can offer higher potential upside if the platform sells at a premium. A meaningful share of the total value can be in equity, so owners often benefit from evaluating that equity as carefully as they would any other investment.

Do I Have To Keep Working After I Sell?

On a DSO deal, a minimum 5-year working agreement is typical, although a shorter work-back may be possible if the owner has already reduced chair time significantly. On a private doctor-to-doctor walk-away sale, the seller usually works back only about 4–8 weeks before exiting. The partnership or vest-out structure sits between these two. The owner transitions gradually over 2–7 years as the associate buys in.

Will The Buyer Take Care Of My Staff And Patients?

Finding the right fit for staff and patients is a central part of McLerran’s mandate, alongside achieving a strong financial outcome. The firm works to identify a buyer whose strategy, structure, and support model align with the legacy the owner wants to leave. McLerran also acts as a buffer between parties during the transaction, which can help protect goodwill and staff relationships during a process that might otherwise feel disruptive.

Is Now A Good Time To Sell?

Demand remains strong for premier, Class A practices, and valuations sit near all-time highs for well-positioned offices. The wave of DSO recapitalizations, secondary sales, and potential IPOs building from more than 20 PE-backed dental platforms seven or more years into their hold periods is expected to reshape the dental acquisition landscape over the next 12 months, which can create additional acquisition activity for high-performing practices. At the same time, tighter financing conditions are narrowing the private-buyer pool for some revenue ranges. McLerran can explain candidly how your specific practice is positioned. If the timing does not look favorable, the firm can update the valuation later instead of pushing a deal that does not align with your goals.

Why Use A Dental-Specific Advisor Instead Of A Local Broker?

A local broker who knows only one or two DSOs often provides limited market exposure, lighter underwriting, and less aggressive bidding. DSOs also tend to bid less aggressively on deals from advisors they see infrequently. McLerran focuses exclusively on dental practices, runs a full competitive process among a vetted national buyer pool, and transacts at roughly 85–90%, compared with an industry norm closer to 35–40%. That difference in transaction rate reflects the quality of the process, the depth of the buyer pool, and the strength of the valuation work that supports the deal through diligence.

Not Sure If Selling Is Right For You Yet? Schedule A Confidential Conversation.

Read Next

• Dental Practice Succession Planning for Owner-Dentists

• Dental Practice Succession Plan Examples: A Practical Guide

• Dental Practice Succession Planning: A Complete Guide

• Dental Practice Succession Planning Checklist

• Dental Practice Transition Options: Private Sale vs. DSO